Novel Method for the Isolation and Characterization of Functional Antigen-specific T-cells

Beckman Coulter Adds Streptamer Technology To Cell-Sorting, Cell-Characterizing Line

  • Beckman Coulters Streptamer technologyBeckman Coulters Streptamer technology

Beckman Coulter, Inc. now offers Streptamer technology, providing a novel method for the isolation and characterization of functional antigen-specific T-cells by fluorescence-activated or magnet-assisted cell sorting. Streptamer technology, manufactured by IBA GmbH, includes Ag-specific multimers available in a number of human alleles and mouse models and attached to either magnetic beads or fluorescently labeled Strep-Tactin.

The addition of the Streptamer technology to Beckman Coulter's iTAg MHC Tetramer and iTopia Immune Monitoring product lines provides researchers with a comprehensive range of methods for sorting and characterizing cells. Combined with current Tetramer and iTopia reagents, Streptamer technology allows researchers to expand their use of tetramers to include in vivo experimentation.
The reversible, antigen-specific staining of T-cells enabled by Streptamers leaves the isolated T-cells phenotypically and functionally indistinguishable from untreated cells. The technology has the potential to advance basic T-cell research as an essential prerequisite for novel immunological medicines.

The partnership with IBA GmbH provides Beckman Coulter with exclusive distribution rights for the Streptamer technology in North America and co-exclusive distribution rights for the IBA Streptamer technology outside of North America. IBA will continue direct sales and support of the Streptamer technology outside of North America.



Beckman Coulter Intl. SA
Postfach 1059
1260 Nyon
Phone: +41 22 3653707
Telefax: +41 22 3653700

Register now!

The latest information directly via newsletter.

To prevent automated spam submissions leave this field empty.